ClassID:

21028

A61K38/47 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof; Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases

Recent Application in this class:
#301
20230391884
2023-12-07

Treatment Of IgE-Mediated Diseases With Antibodies That Specifically Bind CD38

#302
20230390366
2023-12-07

PARAPHARMACEUTICAL OR PHARMACEUTICAL COMPOSITION ADMINISTRABLE TO A LIVING BEING, PREFERABLY A HUMAN BEING, COMPRISING AT LEAST ONE ENZYME FOR THE TREATMENT AND/OR PREVENTION OF BACTERIAL INFECTIONS INVOLVING BIOFILM FORMATION

#303
20230381318
2023-11-30

VISCOSITY-REDUCING EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS

#304
20230381287
2023-11-30

FORMULATIONS COMPRISING GLUCOCEREBROSIDASE AND ISOFAGOMINE

#305
20230372453
2023-11-23

ENGINEERED PROBIOTICS FOR EXPRESSION OF FIBER-SYNTHESIZING ENZYMES IN GUT

#306
20230365692
2023-11-16

STABLE FORMULATIONS OF PROGRAMMED DEATH RECEPTOR 1 (PD-1) ANTIBODIES AND HYALURONIDASE VARIANTS AND FRAGMENTS THEREOF AND METHODS OF USE THEREOF

#307
20230364205
2023-11-16

COMPOSITIONS AND METHODS FOR TREATING SERRATED COLORECTAL CANCER

#308
20230357739
2023-11-09

PH20 polypeptide variants, formulations and uses thereof

#309
20230348615
2023-11-02

Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses

#310
20230346002
2023-11-02

USE OF ISOTHIOCYANATE IN SMOKELESS TOBACCO PRODUCTS

#311
20230338477
2023-10-26

ANTI-TFR:GAA AND ANTI-CD63:GAA INSERTION FOR TREATMENT OF POMPE DISEASE

#312
20230338476
2023-10-26

COACTIVE COMBINATIONS OF ANTIMICROBIALS WITH DISPERSINB

#313
20230331975
2023-10-19

Controlled entrapment and release of molecular cargo

#314
20230330262
2023-10-19

Lipid nanoparticle compositions and methods for mRNA delivery

#315
20230330224
2023-10-19

Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib and Dexamethasone

#316
20230330195
2023-10-19

METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLOGIC DISEASE

#317
20230330185
2023-10-19

METHODS AND COMPOSITIONS FOR TRANSDUCING HEMATOPOIETIC STEM AND PROGENITOR CELLS IN VIVO

#318
20230330149
2023-10-19

ENHANCEMENT OF CARTILAGE REGENERATIVE ACTIVITY OF STEM CELL POPULATIONS BASED ON REDUCTION OF INTRA-ARTICULAR CELLULAR MATERIAL

#319
20230330140
2023-10-19

IMMUNE CELL DELIVERY OF SIALIDASE CANCER CELLS, IMMUNE CELLS AND THE TUMOR MICROENVIRONMENT

#320
20230323371
2023-10-12

POLYNUCLEOTIDES ENCODING ALPHA-GALACTOSIDASE A FOR THE TREATMENT OF FABRY DISEASE

#321
20230321203
2023-10-12

SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF

#322
20230310712
2023-10-05

IMPLANTABLE CELL CHAMBER DEVICE AND USES THEREOF

#323
20230310559
2023-10-05

Use of Amylase or Maltose to Treat or Prevent Neurodegeneration

#324
20230302099
2023-09-28

HYALURONIDASE FUSION PROTEINS COMPRISING A TARGETING SEQUENCE AND METHODS OF USING SAME TO TREAT A COSMETIC CONDITION

#325
20230295593
2023-09-21

PH20 polypeptide variants, formulations and uses thereof

#326
20230295592
2023-09-21

PH20 polypeptide variants, formulations and uses thereof

#327
20230295333
2023-09-21

Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Pomalidomide and Dexamethasone

#328
20230293723
2023-09-21

LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY

#329
20230287381
2023-09-14

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

#330
20230287378
2023-09-14

A GENETICALLY MODIFIED CELL LINE PRODUCING A RECOMBINANT GLYCOPROTEIN HAVING A MANNOSE-TERMINATED N-GLYCAN

#331
20230285593
2023-09-14

Lipid nanoparticle compositions and methods for MRNA delivery

#332
20230285592
2023-09-14

Lipid nanoparticle compositions and methods for MRNA delivery

#333
20230285574
2023-09-14

CONJUGATES OF BIOLOGICALLY ACTIVE MOLECULES TO FUNCTIONALIZED POLYMERS

#334
20230285553
2023-09-14

MATERIALS AND METHODS FOR MITIGATING IMMUNE-SENSITIZATION

#335
20230285519
2023-09-14

B-GLUCURONIDASE PROTEINS HAVING PNEUMOCOCCAL CAPSULE DEGRADING ACTIVITY AND METHODS OF USE

#336
20230285329
2023-09-14

Methods and compositions for the treatment of steatosis-associated disorders

#337
20230285328
2023-09-14

Methods and Compositions for the Treatment of Steatosis-Associated Disorders

#338
20230285291
2023-09-14

MANUFACTURING OF SYNTHETIC EXOSOMES FOR CNS AND NON-CNS DELIVERY OF THERAPEUTICS

#339
20230279435
2023-09-07

Adeno-associated virus variant capsids and methods of use thereof

#340
20230277687
2023-09-07

VIRAL PARTICLES FOR USE IN TREATING TAUOPATHIES SUCH AS ALZHEIMER'S DISEASES BY GENE THERAPY

#341
20230277660
2023-09-07

Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib, Mephalan and Prednisone

#342
20230277633
2023-09-07

PHARMACEUTICAL COMPOSITION OF ENZYMES AND VIRUSES AND APPLICATION THEREOF

#343
20230277632
2023-09-07

MODIFIED PlySs2 LYSINS AND ANTIBIOTIC COMBINATIONS FOR USE AGAINST GRAM-POSITIVE BACTERIA

#344
20230277617
2023-09-07

BIOFILM PREVENTION, DISRUPTION AND TREATMENT WITH BACTERIOPHAGE LYSIN

#345
20230277469
2023-09-07

Implantable device for sustained release of a macromolecular drug compound

#346
20230270864
2023-08-31

EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS

#347
20230263865
2023-08-24

COMPOSITIONS AND METHODS COMPRISING LYSIN PLYCP025 AND DERIVATIVES THEREOF

#348
20230256062
2023-08-17

COMPOSITIONS AND METHODS FOR TREATING LATE-ONSET POMPE DISEASE

#349
20230250409
2023-08-10

PH20 polypeptide variants, formulations and uses thereof

#350
20230241247
2023-08-03

COMPOSITIONS AND METHODS FOR INCREASING OR ENHANCING TRANSDUCTION OF GENE THERAPY VECTORS AND FOR REMOVING OR REDUCING IMMUNOGLOBULINS

#351
20230241187
2023-08-03

Lysosomal Targeting Peptides and Uses Thereof

#352
20230241186
2023-08-03

COMPOSITIONS AND METHODS FOR INHIBITING BIOFILM DEPOSITION AND PRODUCTION

#353
20230235033
2023-07-27

Polypeptides that bind complement component C5 or serum albumin and fusion proteins thereof

#354
20230233676
2023-07-27

Use of Approved Anti-CD38 Antibody Drug Product in Combination with Pomalidomide and Dexamethasone to Treat Multiple Myeloma

#355
20230226225
2023-07-20

ADENO-ASSOCIATED VIRUS FOR THERAPEUTIC DELIVERY TO CENTRAL NERVOUS SYSTEM

#356
20230226159
2023-07-20

METHODS AND COMPOSITIONS FOR TREATING CYTOKINE STORM, ARDS, AND ACUTE LUNG INJURY USING BETA-GLUCOCEREBROSIDASE

#357
20230218505
2023-07-13

Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins

#358
20230212547
2023-07-06

PH20 polypeptide variants, formulations and uses thereof

#359
20230210962
2023-07-06

CONDITIONING REGIMEN FOR TRANSPLANT

#360
20230210961
2023-07-06

Therapeutic use of engineered postbiotics comprising bacteriocins and/or endolysins

#361
20230210884
2023-07-06

Immunomodulating Gene Therapy

#362
20230201373
2023-06-29

CRISPR-MEDIATED GENOME EDITING WITH VECTORS

#363
20230201121
2023-06-29

EFFICIENT AQUEOUS ENCAPSULATION AND CONTROLLED RELEASE OF BIOACTIVE AGENTS

#364
20230183365
2023-06-15

Subcutaneously administered anti-IL-6 receptor antibody

#365
20230181701
2023-06-15

METHODS FOR ENHANCING ADOPTIVE CELL TRANSFER IMMUNOTHERAPIES

#366
20230181655
2023-06-15

THERAPEUTIC AND PROPHYLACTIC TREATMENT FOR COLORECTAL CANCER

#367
20230174575
2023-06-08

A NEW PROCESS OF PURIFICATION OF PROTEINS FROM HEN EGG WHITE AND THE USE OF THE SAME AS ANTIVIRAL AGENT AGAINST SARS-COV-2

#368
20230173108
2023-06-08

COMPOSITIONS USEFUL FOR TREATMENT OF POMPE DISEASE

#369
20230173038
2023-06-08

AEROSOLIZED HYALURONIDASE AND/OR 4-METHYLUMBELLIFERONE COMPOSITIONS AND METHODS OF USING SAME TO TREAT RESPIRATORY DISEASES OR DISORDERS

#370
20230173037
2023-06-08

Manipulating Glycogen in Alzheimer’s Disease, Epilepsy, Traumatic Brain Injury, and ALS as a Treatment

#371
20230167427
2023-06-01

STREPTOCOCCUS BACTERIOPHAGE LYSINS FOR DETECTION AND TREATMENT OF GRAM POSITIVE BACTERIA

#372
20230165942
2023-06-01

CNS DELIVERY OF THERAPEUTIC AGENTS

#373
20230158214
2023-05-25

Method for Treating Tissue

#374
20230158124
2023-05-25

DRUG, FOOD AND APPLICATION OF ANTI-CORONAVIRUS INFECTION

#375
20230158123
2023-05-25

Recombinant Alpha-Galactosidase A For Treatment Of Fabry Disease

#376
20230158109
2023-05-25

USE OF CD83 IN COMBINATION THERAPIES

#377
20230158081
2023-05-25

EGG PROTEIN FORMULATIONS AND METHODS OF MANUFACTURE THEREOF

#378
20230151346
2023-05-18

PH20 polypeptide variants, formulations and uses thereof

#379
20230149428
2023-05-18

METHOD OF TREATING GENE THERAPY ASSOCIATED TOXICITY WITH ANTIBIOTICS

#380
20230148251
2023-05-11

COMPOUND NUTRIENT CAPABLE OF REPAIRING DAMAGED INTESTINES OF PIGELETS AND METHOD OF USING THE SAME

#381
20230144834
2023-05-11

ADENO-ASSOCIATED VIRUS VECTORS ENCODING MODIFIED G6PC AND USES THEREOF

#382
20230142208
2023-05-11

ORAL TERPENE CYCLODEXTRIN INCLUSION COMPLEX VEHICLES

#383
20230140216
2023-05-04

COMBINATION THERAPY FOR TREATING MPS1

#384
20230139230
2023-05-04

EGG PROTEIN FORMULATIONS AND METHODS OF MANUFACTURE THEREOF

#385
20230138700
2023-05-04

COMBINED ANIMAL-DERIVED AND SYNTHETICALLY PRODUCED PANCREATIC ENZYME REPLACEMENT THERAPY

#386
20230137573
2023-05-04

Pharmaceutical Composition for Treating Cancer Comprising Trypsinogen and/or Chymotrypsinogen and an Active Agent Selected from a Selenium Compound, a Vanilloid Compound and a Cytoplasmic Glycolysis Reduction Agent

#387
20230134748
2023-05-04

Corticosteriod Reduction in Treatment with Anti-CD38 Antibody

#388
20230134550
2023-05-04

NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING GAUCHER THERAPEUTICS

#389
20230128911
2023-04-27

MULTI CHAMBER SYRINGE UNIT AND METHOD OF PREPARING A MULTI CHAMBER SYRINGE

#390
20230126007
2023-04-27

NANOPARTICLES ENCAPSULATING SOLUBLE BIOLOGICS, THERAPEUTICS, AND IMAGING AGENTS

#391
20230123505
2023-04-20

METHODS FOR TREATING FARBER DISEASE

#392
20230120142
2023-04-20

COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR BACTERIAL INFECTIONS

#393
20230118104
2023-04-20

COMPOSITIONS AND METHODS FOR TREATING PANCREATIC ENZYME DEFICIENCIES IN MAMMALS

#394
20230117606
2023-04-20

COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR BACTERIAL INFECTIONS

#395
20230111947
2023-04-13

METHODS OF PROPHYLAXIS OF CORONAVIRUS INFECTION AND TREATMENT OF CORONAVIRUSES

#396
20230110588
2023-04-13

VECTOR FOR CANCER TREATMENT

#397
20230107499
2023-04-06

HETEROARYL COMPOUNDS AND THERAPEUTIC USES THEREOF IN CONDITIONS ASSOCIATED WITH THE ALTERATION OF THE ACTIVITY OF BETA-GLUCOCEREBROSIDASE

#398
20230106864
2023-04-06

COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR BACTERIAL INFECTIONS

#399
20230094597
2023-03-30

COMPOSITIONS AND METHODS FOR TREATING DISORDERS CHARACTERIZED WITH EXCESSIVE OSTEOCLAST ACTIVITY

#400
20230092354
2023-03-23

Subcutaneous HER2 antibody formulations

#401
20230089740
2023-03-23

CANCER TREATMENT

#402
20230089121
2023-03-23

NOVEL COMBINATION OF NUCLEIC ACID REGULATORY ELEMENTS AND METHODS AND USES THEREOF

#403
20230085357
2023-03-16

INJECTABLE HIGH CONCENTRATION PHARMACEUTICAL FORMULATIONS AND METHODS OF MANUFACTURING AND USE THEREOF

#404
20230081146
2023-03-16

METHODS AND COMPOSITIONS TO PREVENT AND TREAT INFLAMMATION AND ALLERGIC REACTIONS

#405
20230071924
2023-03-09

PROBIOTIC COMPOSITION TO REDUCE PATHOGENESIS IN POULTRY AND METHODS FOR USE THEREOF

#406
20230067653
2023-03-02

ENGINEERED TARGET SPECIFIC NUCLEASES

#407
20230065872
2023-03-02

EXCIPIENT COMPOUNDS FOR PROTEIN PROCESSING

#408
20230065040
2023-03-02

SUBCUTANEOUS DELIVERY OF MESSENGER RNA

#409
20230056857
2023-02-23

Nanosystems for controlled transport of active molecules for diagnostic, prognostic and therapeutic purposes

#410
20230050560
2023-02-16

LYSIN POLYPEPTIDES ACTIVE AGAINST GRAM-NEGATIVE BACTERIA

#411
20230049239
2023-02-16

COMBINED MULTISTAGE MICROBIAL PREPARATIONS AND METHOD OF THEIR APPLICATION

#412
20230040603
2023-02-09

COMPOSITIONS USEFUL FOR TREATING GM1 GANGLIOSIDOSIS

#413
20230032226
2023-02-02

METHODS PROVIDING A THERAPEUTIC MACROMOLECULE AND SYNTHETIC NANOCARRIERS COMPRISING IMMUNOSUPPRESSANT LOCALLY AND CONCOMITANTLY TO REDUCE BOTH TYPE 1 AND TYPE IV HYPERSENSITIVITY

#414
20230028812
2023-01-26

Viscosity-reducing excipient compounds for protein formulations

#415
20230027396
2023-01-26

EXCIPIENT COMPOUNDS FOR BIOPOLYMER FORMULATIONS

#416
20230026836
2023-01-26

Methods and compositions for CNS delivery of iduronate-2-sulfatase

#417
20230022913
2023-01-26

Conjugates of tumor necrosis factor inhibitors to functionalized polymers

#418
20230012731
2023-01-19

HYALURONIDASE COMPOSITIONS AND METHODS OF USING SAME TO TREAT PERI-ORBITAL HOLLOWNESS AND TEAR THROUGH DEFORMITIES

#419
20230000948
2023-01-05

Compositions and methods for treatment of GCase related disease states

#420
20220411510
2022-12-29

Anti-CD28 Humanized Antibodies Formulated for Administration to Humans

#421
20220406435
2022-12-22

METHODS OF TREATING DEMENTIA ASSOCIATED WITH ALZHEIMER'S DISEASE WITH PROTECTIVE PROTEIN/CATHEPSIN A (PPCA)

#422
20220401559
2022-12-22

EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS

#423
20220401527
2022-12-22

Antimicrobial hevamine A-related compositions and methods

#424
20220395589
2022-12-15

POLYMERIC NANOPARTICLES FOR INTRACELLULAR PROTEIN DELIVERY

#425
20220395548
2022-12-15

HEVAMINE-RELATED PLANT COMPOSITIONS AND METHODS

#426
20220395543
2022-12-15

Compositions for gut health

#427
20220395482
2022-12-15

GLYCOGEN OR POLYSACCHARIDE STORAGE DISEASE TREATMENT METHOD

#428
20220387616
2022-12-08

SIALIDASE-HER2-ANTIBODY FUSION PROTEINS AND METHODS OF USE THEREOF

#429
20220387563
2022-12-08

Polypeptides and antibiotics against gram-negative bacterium comprising the same

#430
20220387562
2022-12-08

COMPOSITIONS AND METHODS FOR TREATING GLYCOGEN STORAGE DISORDERS

#431
20220387561
2022-12-08

TREATMENT OF SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS INFECTION WITH KLOTHO

#432
20220387334
2022-12-08

Nanoparticles for preventing peri/post-menopausal bone loss and/or obesity

#433
20220380744
2022-12-01

METHOD OF TREATING INFECTIONS BY BACTERIOLYTIC ENZYMES AND MANUFACTURE THEREOF

#434
20220378939
2022-12-01

Lipid nanoparticle compositions and methods for mRNA delivery

#435
20220378870
2022-12-01

A composition for boosting the immune system

#436
20220372172
2022-11-24

Method and carrier complexes for delivering molecules to cells

#437
20220372151
2022-11-24

COMBINATION THERAPY WITH A HYALURONAN-DEGRADING ENZYME AND AN IMMUNE CHECKPOINT INHIBITOR

#438
20220370571
2022-11-24

AUGMENTED ACID ALPHA-GLUCOSIDASE FOR THE TREATMENT OF POMPE DISEASE

#439
20220362406
2022-11-17

LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY

#440
20220362354
2022-11-17

WIDE-SPECTRUM ANTIBACTERIAL PHARMACEUTICAL FORMULATIONS COMPRISING LYSOZYME AND METHODS OF USING THE SAME

#441
20220362353
2022-11-17

DRUG COMBINATION FOR PREVENTING OR TREATING IRRITABLE BOWEL SYNDROME

#442
20220362352
2022-11-17

Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby

#443
20220362351
2022-11-17

RECOMBINANT SIALIDASES AND METHODS OF USING THE SAME

#444
20220362234
2022-11-17

Use of Hsp70 as a regulator of enzymatic activity

#445
20220354934
2022-11-10

Lysosomal Targeting Peptides and Uses Thereof

#446
20220348895
2022-11-03

Polypeptide, fusion polypeptide, and antibiotic against gram-negative bacteria comprising same

#447
20220347297
2022-11-03

METHODS OF PERMITTING A SUBJECT TO RECEIVE MULTIPLE DOSES OF RECOMBINANT ADENO-ASSOCIATED VIRUS

#448
20220347272
2022-11-03

HIGH CONCENTRATION ALPHA-GLUCOSIDASE COMPOSITIONS FOR THE TREATMENT OF POMPE DISEASE

#449
20220347244
2022-11-03

RECOMBINANT VACCINIA VIRUS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

#450
20220347101
2022-11-03

ENZYME DELIVERY SYSTEMS AND METHODS OF PREPARATION AND USE

#451
20220339265
2022-10-27

MODULATION OF UBIQUITIN CARBOXY-TERMINAL HYDROLASE LIGASE 1 (UCHL1) EXPRESSION FOR TREATING NEUROLOGICAL DISEASE, DISORDERS, AND INJURIES ASSOCIATED WITH UPPER MOTOR NEURONS

#452
20220331408
2022-10-20

TREATMENT OF GLYCOGEN STORAGE DISEASE (GSD)

#453
20220325265
2022-10-13

GLUCOCEREBROSIDASE MUTANTS

#454
20220323554
2022-10-13

POLYSACCHARIDE-PEPTIDE COMPLEX FOR LOWERING BLOOD SUGAR, BLOOD LIPID AND GLYCOSYLATED HEMOGLOBIN LEVELS, AND PREPARATION METHOD

#455
20220323390
2022-10-13

DIETARY SUPPLEMENT TO PROMOTE GUT HEALTH

#456
20220313874
2022-10-06

Method for treating tissue

#457
20220313710
2022-10-06

COMPOSITIONS AND METHODS USING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS

#458
20220305093
2022-09-29

NK-lysin peptide compositions and methods for their use as antimicrobial/antiviral agents

#459
20220305092
2022-09-29

MEDICAMENT AND FOOD FOR PREVENTING OR TREATING NOVEL CORONAVIRUS PNEUMONIA COVID-19 AND USE THEREOF

#460
20220304920
2022-09-29

Cosmetic Compositions for Skin Health and Methods of Using Same

#461
20220296686
2022-09-22

Method for killing bacteria with an engineered postbiotic

#462
20220296662
2022-09-22

Compositions and methods for promoting a healthy microbial flora in a mammal

#463
20220280532
2022-09-08

Subcutaneously administered anti-IL-6 receptor antibody

#464
20220280440
2022-09-08

METHOD FOR THE MANUFACTURE OF A DOSAGE FORM WITH MUCOADHESIVE PROPERTIES FOR BUCCAL ADMINISTRATION OF BIOLOGICS

#465
20220275101
2022-09-01

Use of Approved Anti-CD38 Antibody Drug Product to Treat Light Chain Amyloidosis

#466
20220273777
2022-09-01

METHODS OF TREATING CELIAC DISEASE

#467
20220273615
2022-09-01

METHODS OF TREATING POMPE DISEASE

#468
20220267794
2022-08-25

COMPOSITIONS, DEVICES, AND METHODS FOR TREATING FABRY DISEASE

#469
20220265785
2022-08-25

COMPOSITION FOR PREVENTING OR TREATING URIC ACID-RELATED DISEASE

#470
20220264926
2022-08-25

Devices and methods for the preparation of a nutritional formula

#471
20220257727
2022-08-18

PHARMACEUTICAL COMPOSITION CONTAINING LYSOZYME AND USE THEREOF

#472
20220257690
2022-08-18

Controlled-release and stratified cyclodextrin inclusion complex vehicles

#473
20220257511
2022-08-18

NANOVESICLES

#474
20220251145
2022-08-11

Adeno-associated virus variant capsids and methods of use thereof

#475
20220249627
2022-08-11

COMPOSITIONS AND METHODS FOR INHIBITING BIOLFILM DEPOSITION AND PRODUCTION

#476
20220241432
2022-08-04

ANTICANCER COMBINATIONS

#477
20220241384
2022-08-04

POLYPEPTIDES FOR TREATMENT OF BACTERIAL INFECTIONS

#478
20220233693
2022-07-28

Antibody Compositions and Methods of Use Thereof

#479
20220233689
2022-07-28

METHODS OF TREATING TUMORS

#480
20220233658
2022-07-28

Recombinant intravenous immunoglobulin (RIVIG) compositions and methods for their production and use

#481
20220233657
2022-07-28

TREATMENT OF MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS

#482
20220233656
2022-07-28

ANTIBACTERIAL COMPOSITION

#483
20220233655
2022-07-28

IMPROVED DELIVERY OF GENE THERAPY VECTORS TO RETINAL CELLS USING A GLYCOSIDE HYDROLASE ENZYME

#484
20220228135
2022-07-21

Chimeric endolysin LYS109 with antimicrobial activity against

#485
20220226357
2022-07-21

METHODS FOR TREATING NEURODEGENERATIVE DISORDERS

#486
20220218798
2022-07-14

COMPOSITIONS AND METHODS FOR PROTECTING AGAINST AIRBORNE PATHOGENS AND IRRITANTS

#487
20220211875
2022-07-07

INTRANASAL ADMINISTRATION OF ADENO-ASSOCIATED VIRUS TO TREAT CENTRAL NERVOUS SYSTEM DISORDERS

#488
20220211822
2022-07-07

LACTATE RESPONSE SYSTEM AND METHODS

#489
20220211637
2022-07-07

RANDOM COPOLYMER STABILIZED NANOPARTICLES ENCAPSULATING SOLUBLE HYDROPHILIC COMPOUNDS

#490
20220204963
2022-06-30

OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF

#491
20220202917
2022-06-30

DEPOLYMERASE CAPABLE OF DEGRADING EXTRACELLULAR POLYMERIC SUBSTANCES OF KLEBSIELLA PNEUMONIAE

#492
20220202916
2022-06-30

COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING GLYCOGEN STORAGE DISEASE TYPE III

#493
20220202915
2022-06-30

SIALYLATED GLYCOPROTEIN COMPOSITONS AND USES THEREOF

#494
20220202718
2022-06-30

Cleavable lipids

#495
20220202044
2022-06-30

FIBROUS MAIZE-BASED ANIMAL FEED WITH GH30 GLUCURONOXYLAN HYDROLASE

#496
20220195011
2022-06-23

Compositions and methods for internalizing enzymes

#497
20220193207
2022-06-23

COMPOSITIONS USEFUL FOR TREATMENT OF POMPE DISEASE

#498
20220193206
2022-06-23

Methods and compositions for treating coronavirus infections

#499
20220193186
2022-06-23

METHOD OF TREATING AND PREVENTING BONE AND JOINT INFECTIONS

#500
20220193129
2022-06-23

B CELLS FOR IN VIVO DELIVERY OF THERAPEUTIC AGENTS AND DOSAGES THEREOF

#501
20220193100
2022-06-23

COMPOSITION CONTAINING GLUCORAPHANIN AND USE THEREOF

#502
20220184187
2022-06-16

Combination treatment for atopic dermatitis

#503
20220175894
2022-06-09

Method of treating pathogenic bacterial infectious diseases

#504
20220168434
2022-06-02

APPLICATION OF TRANSTHYRETIN IN ENTERING EYE AND PREPARING DROP

#505
20220168403
2022-06-02

SUBCUTANEOUS TELOMERASE INHIBITOR COMPOSITIONS AND METHODS FOR USING SAME

#506
20220162575
2022-05-26

Engineering of DNASE enzymes for manufacturing and therapy

#507
20220160845
2022-05-26

Therapeutic agent for disc herniation

#508
20220160843
2022-05-26

LYSINS AND DERIVATIVES THEREOF WITH BACTERICIDAL ACTIVITY AGAINST PSEUDOMONAS AERUGINOSA, IN THE PRESENCE OF HUMAN SERUM

#509
20220160842
2022-05-26

METHOD OF TREATING INFECTIVE ENDOCARDITIS

#510
20220154159
2022-05-19

POLYNUCLEOTIDES

#511
20220152165
2022-05-19

COMBINATION OF NASAL GENE DELIVERY AND ORAL CINNAMIC ACID, OLEAMIDE OR GEMFIBROZIL FOR LYSOSOMAL STOARGE DISORDERS

#512
20220143156
2022-05-12

LYSOZYME HYDROLYSATE FOR PROACTIVE INHIBITORY CONTROL AND CONTROL OF IMPULSIVITY

#513
20220143109
2022-05-12

MICROBIAL STRAINS FOR VIRUS INHIBITION

#514
20220142919
2022-05-12

DYNAMIC COVALENTLY LINKED HYDROGELS AS STABILIZATION NETWORK PLATFORMS

#515
20220133863
2022-05-05

TREATMENT OF SANFILIPPO SYNDROME TYPE B

#516
20220133862
2022-05-05

Methods and compositions for CNS delivery of heparan N-sulfatase

#517
20220133861
2022-05-05

HYALURONIDASE COMPOSITIONS AND METHODS OF USING SAME TO TREAT EDEMA

#518
20220133816
2022-05-05

FEED ADDITIVE FORMULATION AND METHODS OF MAKING AND USING THE SAME

#519
20220127590
2022-04-28

STREPTOCOCCUS BACTERIOPHAGE LYSINS FOR DETECTION AND TREATMENT OF GRAM POSITIVE BACTERIA

#520
20220125892
2022-04-28

GLUCOCEREBROSIDASE POLYPEPTIDES

#521
20220125811
2022-04-28

INJECTABLE COMPOSITION FOR INDUCING LIPOLYSIS AND METHOD USING THE SAME

#522
20220119843
2022-04-21

RECOMBINANT ADENO-ASSOCIATED VIRUS COMPOSITIONS AND METHODS FOR PRODUCING SAME

#523
20220118062
2022-04-21

COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND A MILK THISTLE EXTRACT OR POWDER

#524
20220118061
2022-04-21

Microbial lysozyme for use in the treatment of irritable bowel syndrome or inflammatory bowel disease

#525
20220111072
2022-04-14

Lipid nanoparticle compositions and methods for mRNA delivery

#526
20220111071
2022-04-14

LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY

#527
20220111070
2022-04-14

Lipid nanoparticle compositions and methods for MRNA delivery

#528
20220110977
2022-04-14

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING VIRAL INFECTIONS

#529
20220106579
2022-04-07

Method of Treating Glycogen Storage Disease

#530
20220105203
2022-04-07

CAPPED AND UNCAPPED RNA MOLECULES AND BLOCK COPOLYMERS FOR INTRACELLULAR DELIVERY OF RNA

#531
20220105201
2022-04-07

Lipid nanoparticle compositions and methods for mRNA delivery

#532
20220105179
2022-04-07

GLYCOENGINEERING IMMUNOGLOBULIN E

#533
20220105161
2022-04-07

PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF THE SYMPTOMS OF ADDICTION AND METHOD OF DIAGNOSING SAME

#534
20220098243
2022-03-31

Selective recovery

#535
20220096659
2022-03-31

METHOD FOR IMPROVING NEUROLOGICAL FUNCTION IN MPSI AND MPSII AND OTHER NEUROLOGICAL DISORDERS

#536
20220096607
2022-03-31

SUBCUTANEOUS THERAPEUTIC ENZYME FORMULATIONS, USES, AND METHODS FOR GENERATING THEREOF

#537
20220090038
2022-03-24

Engineered amylase variants

#538
20220089738
2022-03-24

Stable Formulations of Programmed Death Receptor 1 (PD-1) Antibodies and Hyaluronidase Variants and Fragments Thereof and Methods of Use Thereof

#539
20220088151
2022-03-24

Proteolytic enzyme composition

#540
20220079909
2022-03-17

Food Supplement For Improving Sports Performance

#541
20220072151
2022-03-10

Methods and gene therapy constructs for treating GM2 gangliosidoses

#542
20220072109
2022-03-10

Anti inflammatory composition

#543
20220071968
2022-03-10

METHODS OF ADMINISTERING IMMUNOSUPPRESSANTS HAVING A SPECIFIED PHARMACODYNAMIC EFFECTIVE LIFE AND THERAPEUTIC MACROMOLECULES FOR THE INDUCTION OF IMMUNE TOLERANCE

#544
20220071904
2022-03-10

Methods of prophylaxis of coronavirus infection and treatment of coronaviruses

#545
20220064617
2022-03-03

Recombinant Glycoproteins and Uses Thereof

#546
20220064615
2022-03-03

STREPTOCOCCUS BACTERIOPHAGE LYSINS FOR DETECTION AND TREATMENT OF GRAM POSITIVE BACTERIA

#547
20220062423
2022-03-03

EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS

#548
20220062162
2022-03-03

Toner, Lysozyme Buccal Tablet and Preparation Method of Lysozyme Buccal Tablet

#549
20220054603
2022-02-24

STABILIZED LIQUID ENZYME SUPPLEMENT AND USES THEREOF

#550
20220054602
2022-02-24

mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES

#551
20220054601
2022-02-24

Methods and compositions for treating coronavirus infections

#552
20220054600
2022-02-24

ANIMAL FEED COMPOSITIONS AND USES THEREOF

#553
20220047685
2022-02-17

ANIMAL FEED COMPOSITION AND USE THEREOF

#554
20220047614
2022-02-17

COMPOSITIONS AND METHODS FOR PROTECTING AGAINST AIRBORNE PATHOGENS AND IRRITANTS

#555
20220041745
2022-02-10

Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses

#556
20220040330
2022-02-10

Lipid nanoparticle compositions and methods for mRNA delivery

#557
20220040271
2022-02-10

ANIMAL FEED COMPOSITIONS AND USES THEREOF

#558
20220040241
2022-02-10

Feed additive composition

#559
20220040126
2022-02-10

Methods and compositions for the treatment of cytoplasmic glycogen storage disorders

#560
20220040097
2022-02-10

CHEWABLE TABLET

#561
20220033779
2022-02-03

GENETICALLY MODIFIED MESENCHYMAL STEM CELL EXPRESSING KLOTHO

#562
20220031856
2022-02-03

Conjugates of tumor necrosis factor inhibitors to functionalized polymers

#563
20220031817
2022-02-03

ENHANCED THERAPEUTIC USAGE OF A PURINE NUCLEOSIDE PHOSPHORYLASE OR NUCELOSIDE HYDROLASE PRODRUG

#564
20220031816
2022-02-03

CANCER TREATMENT

#565
20220031815
2022-02-03

ANIMAL FEED COMPOSITION AND USE THEREOF

#566
20220023443
2022-01-27

Disulfide bond stabilized polypeptide compositions and methods of use

#567
20220023399
2022-01-27

BLOOD COMPONENT POTENTIATION OF LYTIC PROTEIN ANTI-BACTERIAL ACTIVITY AND METHODS AND USES THEREOF

#568
20220023273
2022-01-27

METHODS FOR TREATING SYMPTOMS AND DISORDERS ASSOCIATED WITH LYSOSOMAL STORAGE DISEASES

#569
20220017884
2022-01-20

Lysin Agent and Method of Use for Diagnostic Testing

#570
20220016263
2022-01-20

FABRY DISEASE GENE THERAPY

#571
20220016092
2022-01-20

METHODS FOR TREATING SYMPTOMS AND DISORDERS ASSOCIATED WITH LYSOSOMAL STORAGE DISEASES

#572
20220008557
2022-01-13

FUSOSOME COMPOSITIONS FOR CNS DELIVERY

#573
20220008520
2022-01-13

METHODS AND MATERIALS FOR REDUCING AGE-RELATED STRIATED MUSCLE AND COGNITIVE DECLINE

#574
20220008519
2022-01-13

TREATMENT OF SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS INFECTION WITH KLOTHO

#575
20220000122
2022-01-06

ANTI-PATHOGENIC ACTIVITY OF A BIFUNCTIONAL PEPTIDOGLYCAN/CHITIN HYDROLASE

#576
20210403592
2021-12-30

Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38

#577
20210403584
2021-12-30

METHODS AND COMPOSITIONS FOR INCREASING GALACTOSIDASE BETA-1 ACTIVITY IN THE CNS

#578
20210401951
2021-12-30

MRNA therapy for pompe disease

#579
20210393775
2021-12-23

Daratumumab and Hyaluronidase for the Treatment of Multiple Myeloma

#580
20210393747
2021-12-23

Recombinant human acid alpha-glucosidase

#581
20210388070
2021-12-16

CO-ADMINISTRATION OF A HYALURONIDASE AND ANTI-C5 ANTIBODY FOR TREATMENT OF COMPLEMENT-ASSOCIATED CONDITIONS

#582
20210386835
2021-12-16

AN ANTIMICROBIAL COMPOSITION FOR SELECTIVELY INHIBITING GROWTH OF P. ACNES BACTERIA

#583
20210386778
2021-12-16

Composition or combination comprising anionic dietary supplement and 25-hydroxy vitamin D

#584
20210380959
2021-12-09

Spherical agglomeration of proteins

#585
20210380643
2021-12-09

Adeno-associated virus variant capsids and methods of use thereof

#586
20210379185
2021-12-09

EXCIPIENT COMPOUNDS FOR PROTEIN PROCESSING

#587
20210369871
2021-12-02

ADENO-ASSOCIATED VIRUS FOR THERAPEUTIC DELIVERY TO CENTRAL NERVOUS SYSTEM

#588
20210369819
2021-12-02

Hyaluronidase for the prevention, treatment, reduction and/or abolishment of cerebral edema and intracranial pressure

#589
20210368827
2021-12-02

Composition and/or combination for aquaculture

#590
20210368788
2021-12-02

METHODS FOR USING ANTIMICROBIAL COMPOSITIONS

#591
20210361752
2021-11-25

Reducing or inhibiting ocular damage by hyaluronidase administration

#592
20210355506
2021-11-18

COMPOSITIONS AND METHODS FOR TREATING GM1 GANGLIOSIDOSIS AND OTHER DISORDERS

#593
20210353753
2021-11-18

Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof

#594
20210353722
2021-11-18

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS

#595
20210353720
2021-11-18

Use of recombinant antibacterial protein Ablysin for effectively killing multidrug-resistant pathogenic bacteria

#596
20210353719
2021-11-18

Microparticle Formulations for Delivery to the Lower and Central Respiratory Tract and Methods of Manufacture

#597
20210348146
2021-11-11

Chimeric bacteriophage lysin with activity against bacteria

#598
20210346473
2021-11-11

ADENO-ASSOCIATED VIRUS MEDIATED GENE TRANSFER TO THE CENTRAL NERVOUS SYSTEM

#599
20210338631
2021-11-04

Systems and methods for treating coronavirus

#600
20210332409
2021-10-28

INHIBITION AND TREATMENT OF GASTROINTESTINAL BIOFILMS